Daisuke Kato

Suggest Changes
Learn More
OBJECTIVES To assess the effect of 25 or 50 mg mirabegron on cardiovascular end-points and adverse drug reactions in real-world Japanese patients with overactive bladder and cardiovascular disease.(More)